Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
Lysyl oxidase-like 2 (LOXL2) is an enzyme that promotes scaffolding of extracellular matrix proteins. Here the authors show that LOXL2 is crucial for pressure-overload induced cardiac fibrosis, and that antibody-mediated inhibition or genetic disruption ofLoxl2in mice shows therapeutic potential for...
Guardado en:
Autores principales: | Jin Yang, Konstantinos Savvatis, Jong Seok Kang, Peidong Fan, Hongyan Zhong, Karen Schwartz, Vivian Barry, Amanda Mikels-Vigdal, Serge Karpinski, Dmytro Kornyeyev, Joanne Adamkewicz, Xuhui Feng, Qiong Zhou, Ching Shang, Praveen Kumar, Dillon Phan, Mario Kasner, Begoña López, Javier Diez, Keith C. Wright, Roxanne L. Kovacs, Peng-Sheng Chen, Thomas Quertermous, Victoria Smith, Lina Yao, Carsten Tschöpe, Ching-Pin Chang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c49e4174d5d4829a56a0c196d697c78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling
por: Caixia Zhang, et al.
Publicado: (2021) -
Bladder pain syndrome/interstitial cystitis is associated with hyperthyroidism.
por: Shiu-Dong Chung, et al.
Publicado: (2013) -
Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
por: Xiang Tong, et al.
Publicado: (2021) -
The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2
por: Philipp Neumann, et al.
Publicado: (2018) -
Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1
por: Francesca Pasutto, et al.
Publicado: (2017)